You are here: Industry Insights > CDMO

News List

Charles River Acquires CDMO Cognate BioServices contractpharma
February 18, 2021
Charles River Laboratories has signed an agreement to acquire Cognate BioServices, a cell and gene therapy contract development and manufacturing organization (CDMO), for approximately $875 million.
Wacker Strengthens Biologics Business contractpharma
February 05, 2021
The Munich, Gemany-based chemical company Wacker is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis from South Korea-based firms Helixmith and Medivate Partners.
MedPharm Launches Scientific Advisory Committee contractpharma
February 05, 2021
MedPharm Ltd, a contract service provider of contract topical and transdermal product design and formulation development services, has launched its Scientific Advisory Committee, headed by company founder and Board member, professor Marc Brown.
Metrics Contract Services Appoints BD VP contractpharma
February 04, 2021
Metrics Contract Services, a full-service contract development and manufacturing organization (CDMO) in novel oral solid dose products, has appointed Britton Jimenez as vice president of business development.
Frontida Expands Testing Capabilities contractpharma
February 03, 2021
Frontida BioPharm has launched its new Category 1 (CAT.ONE) in vitro testing and evaluation services to support development and regulatory approvals for abuse-deterrent formulations of pain management and Central Nervous System (CNS) targeted therapies.
Metrics Contract Services Appoints VP of Business Development contractpharma
February 03, 2021
Metrics Contract Services, a full-service contract development and manufacturing organization (CDMO) in novel oral solid dose products, has appointed Britton Jimenez as vice president of business development.
CDMO WuXi STA Expands Footprint in Europe contractpharma
February 03, 2021
WuXi STA, a subsidiary of WuXi AppTec, has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland.
CDMO Northway Biotech Expands in U.S. contractpharma
January 22, 2021
Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, has opened its new 30,000-square-foot process ...
NovaQuest Private Equity Acquires CoreRx contractpharma
January 20, 2021
NovaQuest Private Equity has acquired CoreRx, a global contract development and manufacturing organization (CDMO).
Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center contractpharma
January 15, 2021
FUJIFILM Corp. and the Center for Advanced Biological Innovation and Manufacturing (CABIM), have secured $76 million in financing and signed a lease for a 40,000 square-foot site in Watertown, MA.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page